Veterinary Artificial Insemination Market to grow with a CAGR of 8.28 %

Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the Global Veterinary Artificial Insemination Market.

 

According to TechSci Research report, “Global Veterinary Artificial Insemination Market Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, Global Veterinary Artificial Insemination Market has valued at USD 2.04 billion in 2022 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 8.28% through 2028. This can be due to collaborations and partnerships among leading companies with a diverse approach to merge the expertise of individual companies and to strengthen their position in the market. Genetic preservation is a significant driver of the demand for the global veterinary artificial insemination market. The preservation of genetic diversity and the propagation of desirable traits in animal populations are key factors motivating the use of artificial insemination. Artificial insemination is widely employed in the conservation of endangered and rare species. It allows for controlled breeding and genetic management of these populations, preventing the loss of unique genetic material and maintaining the viability of these species. Preserving and enhancing genetic diversity within animal populations is essential for their long-term survival and adaptability. Artificial insemination is a valuable tool for maintaining genetic diversity, especially when natural breeding is limited or risky. Artificial insemination enables breeders to selectively choose the best breeding pairs to propagate specific traits and characteristics. This is crucial in livestock breeding to enhance productivity, disease resistance, and other desirable attributes. Artificial insemination can be used to reduce the risk of inbreeding, which can lead to genetic disorders and decreased fitness. Carefully managed breeding programs help maintain healthier and genetically diverse populations.

Veterinary Artificial Insemination (AI) is a reproductive method employed in animal breeding to enable the fertilization of females without the need for natural mating. This process entails the extraction of semen from a male animal and then the deliberate introduction of the semen into the reproductive tract of a female animal, typically employing specialized instruments and procedures.

In August 2020, in a groundbreaking move for the sheep industry, AB Europe, a breeding company, has partnered with Cogent, specialists in bovine genetics, to introduce a novel sexed semen service designed for UK sheep producers. While sexed semen technology has been well-established in cattle genetics, accounting for 30% of inseminations, its adoption in the sheep sector has been notably sluggish, despite initial developments in sheep sexed semen dating back 30 years. This innovative service allows customers to use their own rams for semen collection and provides the flexibility to select either female or male sperm cells. Furthermore, producers can opt for a low concentration of two million cells per ml for commercial artificial insemination (AI) or choose four million cells per ml for AI with a focus on embryo transfer.

Ethical and animal welfare concerns can present significant challenges in the global veterinary artificial insemination market. These concerns revolve around the treatment and well-being of animals involved in the artificial insemination process, as well as broader ethical considerations related to the industry. The treatment and housing of animals in artificial insemination facilities must adhere to high animal welfare standards. Concerns may arise if animals are kept in substandard conditions or subjected to stressful or uncomfortable procedures during the insemination process. Animals can experience stress and discomfort during semen collection, semen processing, and insemination. Ethical concerns arise when these procedures are not carried out with proper care and consideration for the animals' well-being. The methods used to collect semen from male animals must be performed in a way that minimizes discomfort or pain. Techniques like electroejaculation, for instance, must be conducted by skilled professionals to ensure minimal distress to the animal. Artificial insemination should not pose risks to the reproductive health of animals. Ethical concerns arise if insemination procedures result in injuries or long-term health issues for either the male or female animals involved.

 

Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " Global Veterinary Artificial Insemination Market.”

 

Global Veterinary Artificial Insemination Market is segmented based on Animal Type, Product, End User, and by region. Based on the Animal Type, Global Veterinary Artificial Insemination is segmented into Cattle, Swine, Ovine & Caprine, Equine, Others. Ovine refers to animals belonging to the genus Ovis, which includes sheep. Sheep are domesticated ruminant mammals primarily raised for their wool, meat (lamb and mutton), and milk (in some regions). Ovine encompasses various sheep breeds with different characteristics and purposes. Caprine refers to animals belonging to the genus Capra, which includes goats. Goats are another group of domesticated ruminant mammals with a variety of uses, such as milk, meat, and fiber production.

Based on Region, North America held the largest share in the Global Veterinary Artificial Insemination Market. The region boasts a robust veterinary service sector, providing expertise and guidance to livestock producers regarding reproductive management, which includes artificial insemination. The presence of several major players in the veterinary artificial insemination industry, along with healthy competition, has driven innovation and the availability of a variety of services and products. North American universities and research institutions have been actively involved in research related to animal genetics and reproduction. This research contributes to the industry's growth and knowledge base. In North America, there is a growing awareness of animal welfare and sustainable agricultural practices. Artificial insemination allows for better genetic selection and improved animal health, aligning with changing consumer preferences.

 

Some of the major companies operating in the Global Veterinary Artificial Insemination Market include:

• Bovine Elite LLC
• Agtech Inc.
• IMV Technologies
• Tek-Event
• Zoetis Inc.
• Neogen Corporation
• Swine Genetics International
• Select Sires Inc.
• GENEX Cooperative
• Genus PLC (ABS Global)

 

Download Free Sample Report

Customers can also request 10% free customization on this report.

 

“Certain areas, particularly in North America, are projected to exert significant demand for Veterinary Artificial Insemination. The growth in the competitive landscape and the presence of well-established companies in the market, committed to enhance the overall wellbeing of people each year, are expected to contribute to a remarkable growth of the Global Veterinary Artificial Insemination Market in the forecast period," said Mr. Karan Chechi, Research Director with TechSci Research, a research-based Global management consulting firm.

Veterinary Artificial Insemination Market by Animal Type (Cattle, Swine, Ovine & Caprine, Equine, Others), by Product (Normal Semen, Sexed Semen), by End User (Animal Husbandry, Others), By Region, By Competition Forecast & Opportunities, 2018-2028F has evaluated the future growth potential of Global Veterinary Artificial Insemination Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Veterinary Artificial Insemination Market.

 

Contact

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +13322586602

Email: [email protected]

Website: www.techsciresearch.com